United States

Wacker Chemie AG (WCHG.DE)

WCHG.DE on Xetra

19 Jan 2018
Change (% chg)

€-0.50 (-0.29%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Wacker Chemie raises FY 2016 earnings outlook
Thursday, 28 Apr 2016 01:14am EDT 

Wacker Chemie AG:Earnings forecast raised: for FY 2016, EBITDA expected to rise by between 5 and 10 percent when adjusted for special income, while group sales still projected to increase slightly.  Full Article

Wacker Chemie AG issues FY 2016 outlook, to propose FY 2015 dividend
Wednesday, 16 Mar 2016 08:00pm EDT 

Wacker Chemie AG:Dividend proposal of 2.00 euros ($2.24) a share for 2015.For full-year 2016, expects sales to edge up, with EBITDA likely to climb slightly when adjusted for special income​.FY 2016 EBITDA should also advance slightly year over year, when adjusted to exclude solar-sector special income​.Net income is likely to be significantly lower than in 2015 because of higher depreciation.FY 2015 net income climbs 24 percent to 242 million euros.FY 2015 EBITDA of 1.05 billion euros.FY 2015 sales 5.3 billion euros.FY 2016 revenue 5,559 million euros - Thomson Reuters I/B/E/S.FY 2016 EBITDA 980.38 million euros - Thomson Reuters I/B/E/S.FY 2016 net income 152.48 million euros - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Wacker Chemie Wins FDA OK To Make Drug Substance In Chiesi's Retavase

* SAYS OBTAINS FDA APPROVAL TO MANUFACTURE THE DRUG SUBSTANCE IN RETAVASE, A THROMBOLYSIS MEDICATION BY CHIESI‍​ Source text: https://www.wacker.com/cms/en/home/index.jsp Further company coverage: